Ads
related to: lantus solo 100u ml pen
Search results
Results From The WOW.Com Content Network
Insulin glargine sold under the brand name Lantus among others is a long-acting modified form of medical insulin, used in the management of type 1 and type 2 diabetes. [7] It is injected just under the skin . [ 7 ]
Insulin glargine/lixisenatide, sold under the brand name Soliqua among others, is a fixed-dose combination medication that combines insulin glargine and lixisenatide and is used to treat diabetes. The most common side effects include hypoglycemia (low blood glucose), diarrhea, vomiting and nausea (feeling sick).
He then uses an insulin pen as needed for his food and correction boluses. [4] Alternatively, the insulin pump could be connected back to the quick disconnect site on the infusion set when needed. On Sunday night at Lantus injection time, Edelman doses for three-quarters of his basal needs with Lantus and reconnects the pump. [citation needed]
Insulin glargine-yfgn is interchangeable and less expensive than the reference product, insulin glargine (Lantus), which had been approved in 2000. [106] The FDA requires that new insulin products are not inferior to existing insulin products with respect to reduction in hemoglobin A1c.
The onset of action of subcutaneous insulin glargine is somewhat slower than NPH human insulin. It is clear solution as there is no zinc in formula. [9] [better source needed] The biosimilar insulin glargine-yfgn (Semglee) was approved for medical use in the United States in July 2021, [10] and in the European Union in March 2018. [11]
Insulin aspart, sold under the brand name Novolog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [18] It is generally used by injection under the skin (into the abdomen, buttocks, thighs, or upper arms) but may also be used by injection into a vein. [18]
Ad
related to: lantus solo 100u ml pen